(King's College London) An increased understanding of the role of the body's immune system in the development of diseases such as prostate cancer, squamous cell carcinoma, type 1 diabetes, autoimmune liver disease and in the rejection of transplanted organs by some transplant patients, has paved the way for a pioneering research program which aims to develop "enhanced" cells as therapies.
Post new comment